Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

IDEAYA brings in $46mm through Series A round

Executive Summary

Oncology drug discovery start-up IDEAYA Biosciences Inc. raised $46mm through its Series A round. Seed investor 5AM Ventures participated, along with Canaan Partners, Celgene, WuXi Healthcare Ventures, Novartis Institutes for BioMedical Research, and Alexandria Real Estate. Canaan joined the company's board of directors and Celgene and WuXi joined as board advisors.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies